Kyle W. Mack, J.D., Pharm.D.

Dr. Mack concentrates his practice on pharmaceutical product liability and health effects litigation, as well as providing counsel to pharmaceutical and medical device manufacturers regarding FDA regulatory compliance matters, labeling, facility inspections, FDA 483 responses, FDA warning letters, and product recalls. He has represented some of the largest pharmaceutical companies across the U.S., including GlaxoSmithKline and AbbVie. Dr. Mack also counsels health systems regarding state and federal regulations pertaining to the practice of pharmacy. He was the first accepted candidate and graduate of the University at Buffalo’s dual doctoral program in pharmacy and law. His pharmacology and medical expertise has consistently provided clients with an advantage in developing scientific defenses, performing causation analyses, as well as handling expert witnesses from initial retention through deposition and Daubert challenge.